References
1
Toffano G, Leon A, Benvegnu D. Effect of brain cortex phospholipids on catechol-amine content of mouse brain.
Pharmacol Res Commun. 1976;8:581-590.
2
LaBrake CC, Fung LW. Phospholipid vesicles promote human hemoglobin oxidation.
J Biol Chem. 1992;267:16703-16711.
3
Orlando P, Cerrito F, Zirili P. The fate of doubly-labelled brain phospholipids administered to mice.
Farmaco. 1975;30:451-458.
4
Gindin J, Novikov M, Kedar D, et al. The effect of plant phosphatidylserine on age-associated memory impairment and mood in the functioning elderly. Geriatric Institute for Education and Research and Dept of Geriatrics; Kaplan Hospital; Rehovot, Israel; 1995.
5
Crook TH III, Adderly BD.
The Memory Cure: The Safe, Scientifically Proven Breakthrough That Can Slow, Halt, Or Even Reverse Age-Related Memory Loss. New York, NY: Pocket Books; 1998:71,72.
6
Gaby AR. Don't believe everything you read.
Townsend Letter for Doctors and Patients.
May 1997:122-123.
7
Gindin J, Novikov M, Kedar D, et al. The effect of plant phosphatidylserine on age-associated memory impairment and mood in the functioning elderly. Geriatric Institute for Education and Research and Dept of Geriatrics; Kaplan Hospital; Rehovot, Israel; 1995.
8
Amaducci L. Phosphatidylserine in the treatment of Alzheimer’s disease: Results of a multicenter study.
Psychopharmacol Bull. 1988;24:130-134.
9
Crook TH, Tinklenberg J, Yesavage J, et al. Effects of phosphatidylserine in age-associated memory impairment.
Neurology. 1991;41:644-649.
10
Crook T, Petrie W, Wells C, et al. Effects of phosphatidylserine in Alzheimer’s disease.
Psychopharmacol Bull. 1992;28:61-66.
11
Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, et al. Double-blind randomized controlled study of phosphatidylserine in senile demented patients.
Acta Neurol Scand. 1986;73:136-140.
12
Engel RR, Satzger W, Gunther W, et al. Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type.
Eur Neuropsychopharmacol.
1992;2:149-155.
13
Funfgeld EW, Baggen M, Nedwidek P, et al. Double-blind study with phosphatidylserine (PS) in Parkinsonian patients with senile dementia of Alzheimer’s type (SDAT).
Prog Clin Biol Res. 1989;317:1235-1246.
14
Nerozzi D, Aceti F, Melia E, et al. Phosphatidylserine and memory disorders in the aged [in Italian; English abstract].
Clin Ther. 1987;120:399-404.
15
Palmieri G, Palmieri R, Inzoli MR, et al. Double-blind controlled trial of phosphatidylserine in patients with senile mental deterioration.
Clin Trials J. 1987;24:73-83.
16
Villardita C, Grioli S, Salmeri G, et al. Multicentre clinical trial of brain phosphatidylserine in elderly patients with intellectual deterioration.
Clin Trials J. 1987;24:84-93.
17
Cenacchi T, Bertoldin T, Farina C, et al. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration.
Aging(Milano). 1993;5:123-133.
18
Crook TH, Tinklenberg J, Yesavage J, et al. Effects of phosphatidylserine in age-associated memory impairment.
Neurology.
1991;41:644-649.
19
Maggioni M, Picotti GB, Bondiolotti GP, et al. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders.
Acta Psychiatr Scand. 1990;81:265-270.
20
Brambilla F, Maggioni M, Panerai AE, et al. Beta-endorphin concentration in peripheral blood mononuclear cells of elderly depressed patients—effects of phosphatidylserine therapy.
Neuropsychobiology.
1996;34:18-21.
21
Fahey TD, Pearl M. Hormonal effects of phosphatidylserine during 2 weeks of intense training. Abstract presented at: National Meeting of the American College of Sports Medicine; June, 1998; Orlando, Florida.
22
Monteleone P, Maj M, Beinat L, et al. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men.
Eur J Clin Pharmacol. 1992;42:385-388.
23
Fahey TD, Pearl M. The hormonal and perceptive effects of phosphatidylserine administration during two weeks of resistive exercise-induced overtraining.
Biol Sport.
1998;15:135-144.
24
Cenacchi T, Bertoldin T, Farina C, et al. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration.
Aging(Milano). 1993;5:123-133.
25
Amaducci L. Phosphatidylserine in the treatment of Alzheimer’s disease: Results of a multicenter study.
Psychopharmacol Bull. 1988;24:130-134.
26
Crook T, Petrie W, Wells C, et al. Effects of phosphatidylserine in Alzheimer’s disease.
Psychopharmacol Bull. 1992;28:61-66.
27
Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, et al. Double-blind randomized controlled study of phosphatidylserine in senile demented patients.
Acta Neurol Scand. 1986;73:136-140.
28
Engel RR, Satzger W, Gunther W, et al. Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type.
Eur Neuropsychopharmacol.
1992;2:149-155.
29
Funfgeld EW, Baggen M, Nedwidek P, et al. Double-blind study with phosphatidylserine (PS) in Parkinsonian patients with senile dementia of Alzheimer’s type (SDAT).
Prog Clin Biol Res. 1989;317:1235-1246.
30
Nerozzi D, Aceti F, Melia E, et al. Phosphatidylserine and memory disorders in the aged [in Italian; English abstract].
Clin Ther. 1987;120:399-404.
31
Palmieri G, Palmieri R, Inzoli MR, et al. Double-blind controlled trial of phosphatidylserine in patients with senile mental deterioration.
Clin Trials J. 1987;24:73-83.
32
Villardita C, Grioli S, Salmeri G, et al. Multicentre clinical trial of brain phosphatidylserine in elderly patients with intellectual deterioration.
Clin Trials J. 1987;24:84-93.
33
Crook TH, Tinklenberg J, Yesavage J, et al. Effects of phosphatidylserine in age-associated memory impairment.
Neurology. 1991;41:644-649.
34
Fahey TD, Pearl M. Hormonal effects of phosphatidylserine during 2 weeks of intense training. Abstract presented at: National Meeting of the American College of Sports Medicine; June, 1998; Orlando, FL.
35
Fahey TD, Pearl M. Hormonal effects of phosphatidylserine during 2 weeks of intense training. Abstract presented at: National Meeting of the American College of Sports Medicine;June, 1998; Orlando, FL.
36
Monteleone P, Maj M, Beinat L, et al. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men.
Eur J Clin Pharmacol. 1992;42:385-388.
37
Monteleone P, Maj M, Beinat L, et al. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men.
Eur J Clin Pharmacol. 1992;42:385-388.
38
Fahey TD, Pearl M. The hormonal and perceptive effects of phosphatidylserine administration during two weeks of resistive exercise-induced overtraining.
Biol Sport.
1998;15:135-144.
39
Monteleone P, Beinat L, Tanzillo C, et al. Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans.
Neuroendocrinology.
1990;52:243-248.
40
Cenacchi T, Bertoldin T, Farina C, et al. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration.
Aging(Milano). 1993;5:123-133.
41
Cenacchi B, Baggio C, Palm E. Human tolerability of oral phosphatidylserine assessed through laboratory examinations.
Clin Trials J.
1987;24:125-130.
42
van den Besselaar AM. Phosphatidylethanolamine and phosphatidylserine synergistically promote heparin’s anticoagulant effect.
Blood Coagul Fibrinolysis. 1995;6:239-244.
43
Blokland A, Honig W, Brouns F, et al. Cognition-enhancing properties of subchronic phosphatidylserine (PS) treatment in middle-aged rats: comparison of bovine cortex PS with egg PS and soybean PS.
Nutrition. 1999;15:778-783.
44
Furushiro M, Suzuki S, Shishido Y, et al. Effects of oral administration of soybean lecithin transphosphatidylated phosphatidylserine on impaired learning of passive avoidance in mice.
Jpn J Pharmacol. 1997;75:447-450.
45
Suzuki S, Yamatoya H, Sakai M, et al. Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats.
J Nutr.
2001;131:2951-2956.
46
Sakai M, Yamatoya H, Kudo S. Pharmacological effects of phosphatidylserine enzymatically synthesized from soybean lecithin on brain functions in rodents.
J Nutr Sci Vitaminol
(Tokyo). 1996;42:47-54.
47
Jorissen BL, Brouns F, Van Boxtel MP, et al. The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment.
Nutr Neurosci.
2001;4:121-134.
48
Kingsley MI, Wadsworth D, Kilduff LP et al. Effects of phosphatidylserine on oxidative stress following intermittent running.
Med Sci Sports Exerc. 2005;37:1300-1306.
49
Kingsley MI, Miller M, Kilduff LP, et al. Effects of phosphatidylserine on exercise capacity during cycling in active males.
Med Sci Sports Exerc. 2006;38:64-71.
50
Hellhammer J, Fries E, Buss C, et al. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress.
Stress.
2004;7:119-126.
51
Kingsley MI, Kilduff LP, McEneny J, et al. Phosphatidylserine supplementation and recovery following downhill running.
Med Sci Sports Exerc.
2006;38:1617-1625.
52
Jager R, Purpura M, Geiss KR, et al. The effect of phosphatidylserine on golf performance.
J Int Soc Sports Nutr.
2007 Dec 4.
53
Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD.
Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial.
Dement Geriatr Cogn Disord.
2010;29(5):467-474.